BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11751948)

  • 1. Requirement for NK cells in CD40 ligand-mediated rejection of Philadelphia chromosome-positive acute lymphoblastic leukemia cells.
    Gruber TA; Skelton DC; Kohn DB
    J Immunol; 2002 Jan; 168(1):73-80. PubMed ID: 11751948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Stripecke R; Skelton DC; Pattengale PK; Shimada H; Kohn DB
    Hum Gene Ther; 1999 Sep; 10(13):2109-22. PubMed ID: 10498243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor.
    Stripecke R; Skelton DC; Gruber T; Afar D; Pattengale PK; Witte ON; Kohn DB
    Hum Gene Ther; 1998 Sep; 9(14):2049-62. PubMed ID: 9759932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
    Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice against Philadelphia chromosome-positive acute lymphoblastic leukemia by cell-based vaccination using nonviral, minimalistic expression vectors and immunomodulatory oligonucleotides.
    Köchling J; König-Merediz SA; Stripecke R; Buchwald D; Korte A; Von Einsiedel HG; Sack F; Henze G; Seeger K; Wittig B; Schmidt M
    Clin Cancer Res; 2003 Aug; 9(8):3142-9. PubMed ID: 12912966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and synergistic control of Ph(+) ALL by a DNA vaccine and 6-mercaptopurine.
    Köchling J; Rott Y; Arndt S; Marschke C; Schmidt M; Wittig B; Kalies K; Westermann J; Henze G
    Vaccine; 2012 Sep; 30(41):5949-55. PubMed ID: 22841975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses.
    Stripecke R; Cardoso AA; Pepper KA; Skelton DC; Yu XJ; Mascarenhas L; Weinberg KI; Nadler LM; Kohn DB
    Blood; 2000 Aug; 96(4):1317-26. PubMed ID: 10942373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant murine interleukin-12 elicits potent antileukemic immune responses in a murine model of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Gruber TA; Skelton DC; Kohn DB
    Cancer Gene Ther; 2005 Oct; 12(10):818-24. PubMed ID: 15877085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to green fluorescent protein: implications for gene therapy.
    Stripecke R; Carmen Villacres M; Skelton D; Satake N; Halene S; Kohn D
    Gene Ther; 1999 Jul; 6(7):1305-12. PubMed ID: 10455440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor immune responses derived from transgenic expression of CD40 ligand in myeloma cells.
    Liu Y; Qureshi M; Xiang J
    Cancer Biother Radiopharm; 2002 Feb; 17(1):11-8. PubMed ID: 11915168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response.
    Chiodoni C; Paglia P; Stoppacciaro A; Rodolfo M; Parenza M; Colombo MP
    J Exp Med; 1999 Jul; 190(1):125-33. PubMed ID: 10429676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.
    Nakajima A; Kodama T; Morimoto S; Azuma M; Takeda K; Oshima H; Yoshino S; Yagita H; Okumura K
    J Immunol; 1998 Aug; 161(4):1901-7. PubMed ID: 9712059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering of murine NK cells by CD40 and CD86 (B7-2).
    Martín-Fontecha A; Assarsson E; Carbone E; Kärre K; Ljunggren HG
    J Immunol; 1999 May; 162(10):5910-6. PubMed ID: 10229827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological and antitumor effects of CD40L on ovarian cancer cell line OVHM].
    Zhang ZM; Zhang C; Zhang FH; Shan BE; Nakagawn S; Tagawa M
    Ai Zheng; 2006 Sep; 25(9):1102-7. PubMed ID: 16965650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Hamada H; Azuma M; Asano S
    Int J Cancer; 1997 Nov; 73(4):556-61. PubMed ID: 9389572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon gamma: its role in the elicitation of an effective antitumor immune response.
    Jyothi MD; Khar A
    Cancer Immunol Immunother; 2000 Dec; 49(10):563-72. PubMed ID: 11129327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved therapeutic outcome following combination immunogene vaccination therapy in murine myeloma.
    Li ZH; Wen XY; Mandelbaum S; Falcioni N; Hawley TS; Hawley RG; Stewart AK
    Leuk Lymphoma; 2003 Oct; 44(10):1775-84. PubMed ID: 14692533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity.
    Nakazaki Y; Tani K; Lin ZT; Sumimoto H; Hibino H; Tanabe T; Wu MS; Izawa K; Hase H; Takahashi S; Tojo A; Azuma M; Hamada H; Mori S; Asano S
    Gene Ther; 1998 Oct; 5(10):1355-62. PubMed ID: 9930341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.